Ainos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ainos and other ETFs, options, and stocks.About AIMD
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its medtech solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA.
CEOChun Hsien Tsai
CEOChun Hsien Tsai
Employees44
Employees44
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1984
Founded1984
Employees44
Employees44
AIMD Key Statistics
Market cap10.25M
Market cap10.25M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume33.93K
Average volume33.93K
High today—
High today—
Low today—
Low today—
Open price$2.29
Open price$2.29
Volume0.00
Volume0.00
52 Week high$5.00
52 Week high$5.00
52 Week low$1.78
52 Week low$1.78
Stock Snapshot
The current Ainos(AIMD) stock price is $2.10, with a market capitalization of 10.25M. The stock trades at a price-to-earnings (P/E) ratio of -0.51.
On 2025-12-16, Ainos(AIMD) stock opened at $2.29, reached a high of —, and a low of —.
The Ainos(AIMD)'s current trading volume is 0, compared to an average daily volume of 33.93K.
In the last year, Ainos(AIMD) shares hit a 52-week high of $5.00 and a 52-week low of $1.78.
In the last year, Ainos(AIMD) shares hit a 52-week high of $5.00 and a 52-week low of $1.78.
AIMD News
Simply Wall St 4d
Ainos Has Debt But No Earnings; Should You Worry?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the vol...
People also own
Based on the portfolios of people who own AIMD. This list is generated using Robinhood data, and it’s not a recommendation.